STEPHEN HALL, F.R.A.C.P.; GENE G. HUNDER, M.D.
To the editor: The prospective analysis by Shelhamer and colleagues (1) of 20 patients seen at the National Institute of Health is a valuable contribution to the study of Takayasu's arteritis. We have recently reported a similar, though retrospective, study of 32 patients seen at our institution (2).
In Shelhamer and colleagues' study, patients were considered to have an unsatisfactory response to corticosteroid treatment if there was angiographic progression of arterial lesions. This criterion assumes that inflammation alone is the cause of arterial lesions and that inflammation must still be present if arterial lesions progress. While this may be true,
HALL S, HUNDER GG. Treatment of Takayasu's Arteritis. Ann Intern Med. ;104:288. doi: 10.7326/0003-4819-104-2-288_2
Download citation file:
Published: Ann Intern Med. 1986;104(2):288.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use